This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Olayan Financing invests in MS Pharma
Business equity investment

Olayan Financing invests in MS Pharma

Analysis based on 7 articles · First reported May 18, 2026 · Last updated May 18, 2026

Sentiment
70
Attention
3
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The investment by Olayan Financing Company in Lewis Pharmacy is expected to boost Lewis Pharmacy's growth, particularly in the biosimilars market across the Europe, the Middle East and Africa region, potentially increasing its market share and revenue. This strategic partnership also signals increased investment confidence in the pharmaceutical sector within Saudi Arabia, aligning with its Saudi Vision 2030 goals for economic diversification and local content.

Pharmaceuticals Biotechnology Investment Services
Event Summary

Lewis Pharmacy announced that Olayan Financing Company (OFC) has made a minority equity investment in the company. This strategic partnership involves Lewis Pharmacy issuing new share capital in exchange for a substantial cash investment from OFC, strengthening Lewis Pharmacy's financial position and flexibility. The investment will accelerate Lewis Pharmacy's growth plans in the Europe, the Middle East and Africa region, supporting the expansion of its biosimilars portfolio, manufacturing capabilities, and supply chain resilience. Key figures like Ghiath Sukhtian, Chairman of Lewis Pharmacy, Kalle Känd, CEO of Lewis Pharmacy, and Nabeel Al-Amudi, CEO of Olayan Financing Company, expressed optimism about the partnership. The collaboration also reinforces Lewis Pharmacy's commitment to localization under the Saudi National Biotechnology Strategy and Saudi Vision 2030, especially in Saudi Arabia where its biologics site received SFDA GMP approval.

Entities Involved
priv
Lewis Pharmacy
Lewis Pharmacy received a substantial cash investment from Olayan Financing Company, strengthening its financial position and enabling expansion in the MENA region, particularly in biosimilars and manufacturing capabilities. This partnership will accelerate its growth and market reach.
Importance 100.0 Sentiment 75.0
priv
Olayan Financing Company
Olayan Financing Company made a minority equity investment in Lewis Pharmacy, marking the beginning of a long-term partnership. This investment aligns with its long-term investment philosophy and expands its portfolio in the pharmaceutical sector.
Importance 90.0 Sentiment 60.0
loc
Europe, the Middle East and Africa
The MENA region is a primary target for Lewis Pharmacy's growth and expansion plans, supported by the investment from Olayan Financing Company.
Importance 50.0 Sentiment 30.0
per
Ghiath Sukhtian
Ghiath Sukhtian, Chairman of Lewis Pharmacy, expressed delight in welcoming Olayan Financing Company as partners, highlighting their expertise and value addition to Lewis Pharmacy.
Importance 40.0 Sentiment 50.0
per
Kalle Känd
Kalle Känd, CEO of Lewis Pharmacy, stated that the investment will deepen expertise in biologics, expand reach in Saudi Arabia and the MENA region, and accelerate growth in biosimilars.
Importance 40.0 Sentiment 50.0
per
Nabeel Al-Amudi
Nabeel Al-Amudi, CEO of Olayan Financing Company, expressed pleasure in partnering with Lewis Pharmacy, recognizing its leadership in the pharmaceutical platform and supporting its continued expansion.
Importance 40.0 Sentiment 50.0
oth
Saudi Vision 2030
Lewis Pharmacy's commitment to localization and expansion in Saudi Arabia aligns with the goals of Saudi Vision 2030, particularly in economic diversification and local content.
Importance 30.0 Sentiment 20.0
govactor
Saudi Arabia — Saudi Food and Drug Authority
Importance 0.0 Sentiment 0.0
cnt
Saudi Arabia
Importance 0.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.